Fludeoxyglucose

DB15107InvestigationalSmall molecule

Fludeoxyglucose is a radiopharmaceutical indicated for PET scans. Fludeoxyglucose is under investigation in clinical trial NCT03262389 (Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma).

Chemical structure of Fludeoxyglucose
Formula / weight
C6H11FO5 · 182.147 g/mol (avg)

Resolves to

Compound
UNIIZO2JV75L55CAS29702-43-0ChEMBLCHEMBL1908940ChEBI49135
Structure
InChIKeyAOYNUTHNTBLRMT-SLPGGIOYSA-NSMILESOC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](F)C=O

What you can answer from here — as of April 23, 2025

13Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
2Marketed productsAcross 1 country and 1 labeller
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Fludeoxyglucose, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In